The US Food and Drug Administration (FDA) is aware of the shortage situation for intravenous (IV) solutions, particularly of 0.9% sodium chloride injection, which is used for hydration and other conditions, and is working on the problem, the agency said today.
"The shortage has been triggered by a range of factors including a potential increase in use by hospitals, potentially related to the flu season," the agency said.
The FDA added that it is working with Baxter Healthcare Corp, B. Braun Medical Inc, and Hospira Inc, which manufacture these products, to help preserve the supply.
"Millions of these IV solutions are used each week by health care professionals," the FDA notes. "Addressing the shortage will depend on the increased demand and the manufacturing production of the current suppliers."
Health providers can stay up to date of the shortage by visiting the FDA's drug shortage Web page for updates and contacting the manufacturers directly.